Editorial: Reviews in opioid use disorders
Wendy Walwyn, Kirk E. Evoy, Kirk E. Evoy
doaj +1 more source
Lessons from COVID-19 for improving delivery of medications for opioid use disorder in future pandemic events: results from a Puerto Rico Delphi consensus panel. [PDF]
Abadie R, Fisher C.
europepmc +1 more source
"Convenience, Quickness, and Compassion": Experiences of People Involved in the Criminal-Legal System Accessing Medications for Opioid Use Disorder Services From a Mobile Unit in Chicago. [PDF]
Martinford T +7 more
europepmc +1 more source
Rurality weakens the positive association between the COVID-19 pandemic and substance use treatment involving medications for opioid use disorder. [PDF]
Lofaro RJ +3 more
europepmc +1 more source
Pre-exposure prophylaxis (PrEP) and medications for opioid use disorder for persons who inject drugs: the CHORUS + randomized controlled trial study protocol. [PDF]
Miller SE +14 more
europepmc +1 more source
Medicaid Patients With ED Visits For Overdose: Disparities In Initiation Of Medications For Opioid Use Disorder. [PDF]
Nguyen T +6 more
europepmc +1 more source
Aligning Efforts to Boost Medications for Opioid Use Disorder and Pre-Exposure Prophylaxis for HIV. [PDF]
Tilhou AS, Assoumou SA, Samet JH.
europepmc +1 more source
Training in medications for opioid use disorder and buprenorphine prescribing in the post X-waiver era: Insights from a nationwide, multispecialty survey. [PDF]
Kim-Vences SIH +6 more
europepmc +1 more source
Concerns About Medications for Opioid Use Disorder Among American Indian Community Members: A Qualitative Secondary Analysis. [PDF]
Grubin F +5 more
europepmc +1 more source

